company background image
EEP logo

Euroespes BME:EEP Stock Report

Last Price

€0.34

Market Cap

€3.7m

7D

0%

1Y

-29.2%

Updated

28 Feb, 2024

Data

Company Financials

EEP Stock Overview

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally.

EEP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Euroespes, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Euroespes
Historical stock prices
Current Share Price€0.34
52 Week High€0.49
52 Week Low€0.32
Beta0.030
11 Month Change0%
3 Month Change0%
1 Year Change-29.17%
33 Year Change-30.61%
5 Year Change-56.13%
Change since IPO-88.36%

Recent News & Updates

Would Euroespes (BME:EEP) Be Better Off With Less Debt?

Nov 11
Would Euroespes (BME:EEP) Be Better Off With Less Debt?

Recent updates

Would Euroespes (BME:EEP) Be Better Off With Less Debt?

Nov 11
Would Euroespes (BME:EEP) Be Better Off With Less Debt?

Here's Why Euroespes (BME:EEP) Can Afford Some Debt

May 10
Here's Why Euroespes (BME:EEP) Can Afford Some Debt

Shareholder Returns

EEPES Life SciencesES Market
7D0%-5.1%-1.5%
1Y-29.2%-17.8%13.3%

Return vs Industry: EEP underperformed the Spanish Life Sciences industry which returned -16.7% over the past year.

Return vs Market: EEP underperformed the Spanish Market which returned 7.5% over the past year.

Price Volatility

Is EEP's price volatile compared to industry and market?
EEP volatility
EEP Average Weekly Movementn/a
Life Sciences Industry Average Movement6.6%
Market Average Movement3.0%
10% most volatile stocks in ES Market6.0%
10% least volatile stocks in ES Market0.7%

Stable Share Price: EEP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EEP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199139Ramon Cacabelos Garciawww.euroespes.com

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology.

Euroespes, S.A. Fundamentals Summary

How do Euroespes's earnings and revenue compare to its market cap?
EEP fundamental statistics
Market cap€3.67m
Earnings (TTM)-€1.14m
Revenue (TTM)€3.86m

1.0x

P/S Ratio

-3.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EEP income statement (TTM)
Revenue€3.86m
Cost of Revenue€2.47m
Gross Profit€1.38m
Other Expenses€2.52m
Earnings-€1.14m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin35.92%
Net Profit Margin-29.49%
Debt/Equity Ratio68.3%

How did EEP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.